showed that the downregulation of LPAR5 expression could inhibit the physiological process of papillary thyroid cancer via PI3K/AKT pathway and epithelial-mesenchymal transition (EMT) process (67). This evidence concerns the gene AKT1 and thyroid gland papillary carcinoma.